Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-02 Musso Alan A Chief Financial Officer Grant or award · Stock Option (right to buy) +170,000 170,000
2025-01-24 Musso Alan A Chief Financial Officer Grant or award · Stock Option (right to buy) +285,000 285,000
2024-01-26 Musso Alan A Chief Financial Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2024-01-17 Musso Alan A Chief Financial Officer Grant or award · Stock Option (right to buy) +61,822 61,822
2023-08-07 Musso Alan A Chief Financial Officer Grant or award · Stock Option (right to buy) +432,800 432,800

Page 1 of 1 · 5 trades